According to Pear Therapeutics's latest financial reports the company has a price-to-book ratio of 0.1363.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 3.15 | -66.64% |
2021-12-31 | 9.45 | |
2020-12-31 | N/A |